Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
One to two weeks later the participants were given the drug they did not initially receive
Phase 2 trial data (NEJM, 2023) showed promising weight reduction results, but long-term safety and cardiovascular outcomes remain under investigation in ongoing Phase 3 trials
180-Day Guarantee Risk-free trial with full refund available if not satisfied. Gentle & Clean Formula Free from fragrance, alcohol, parabens, dyes, and other harsh additives
Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ and Wolf CR
51-OR: A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-finding Study of BI 456906 in people with overweight/obesity
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
